By vgreene, 15 March, 2021 Ivermectin Shows Clinical Benefits in Mild to Moderate COVID19 A Randomised Controlled Double blind Dose response Study in Lagos OJM article
By vgreene, 15 March, 2021 Role of Ivermectin in the Prevention of SARS CoV 2 Infection Among Healthcare Workers in India A Matched Case Control Study PLoS One article
By vgreene, 15 March, 2021 Effectiveness of Ivermectin in SARS CoV 2 COVID 19 Patients Int J Sci article
By vgreene, 15 March, 2021 Ivermectin Treatment May Improve the Prognosis of Patients With COVID 19 Arch Bronconeumol article
By vgreene, 15 March, 2021 Study considerations meta analysis incl 4 observational studies quality of evidence low publication bias due to small sample size
By vgreene, 15 March, 2021 KEY FINDINGS reduced all cause mortality and significant clinical improvement w add on ivermectin tx
